Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Lanx Inc.
EnteroMedics appoints president and CEO; former Medtronic chair elected to Halyard Health Board of Directors; T2 Biosystems names chief commercial officer; AngioDynamics CFO transition; new Merit Medical Systems CFO tapped.
Medtech VCs Show Steady Hand With Dollars Invested in 2013
Despite contraction in the number of funds and VC firms investing in life sciences, 2013 was a strong year for private investing in medtech, with private investors putting $2.54 million into 129 medical device deals, according to Informa’s Strategic Transactions. Looking at where investors placed their money revealed some emerging trends.
Spine Tingling After LDR Holdings’ IPO
Spine company LDR Holdings Corp. helped signal a turnaround in the spine industry with a successful IPO in October, netting $80 million. Privately, venture capitalists are reporting greater interest in their companies from Wall Street bankers, but should LDR’s success be seen as a strong signal for devices?
Deals Shaping The Medical Industry, November 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced September through October 2013.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.